Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

ZBTB7A promotes migration, invasion and metastasis of human breast cancer cells through NF-κB-induced epithelial-mesenchymal transition in vitro and in vivo.

Mao A, Chen M, Qin Q, Liang Z, Jiang W, Yang W, Wei C.

J Biochem. 2019 Aug 6. pii: mvz062. doi: 10.1093/jb/mvz062. [Epub ahead of print]

PMID:
31385585
2.
3.

VEGF/NRP-1axis promotes progression of breast cancer via enhancement of epithelial-mesenchymal transition and activation of NF-κB and β-catenin.

Luo M, Hou L, Li J, Shao S, Huang S, Meng D, Liu L, Feng L, Xia P, Qin T, Zhao X.

Cancer Lett. 2016 Apr 1;373(1):1-11. doi: 10.1016/j.canlet.2016.01.010. Epub 2016 Jan 19.

4.

Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.

Ma X, Yan W, Dai Z, Gao X, Ma Y, Xu Q, Jiang J, Zhang S.

Drug Des Devel Ther. 2016 Apr 18;10:1419-41. doi: 10.2147/DDDT.S102541. eCollection 2016.

5.

RNF8 promotes epithelial-mesenchymal transition of breast cancer cells.

Kuang J, Li L, Guo L, Su Y, Wang Y, Xu Y, Wang X, Meng S, Lei L, Xu L, Shao G.

J Exp Clin Cancer Res. 2016 Jun 4;35(1):88. doi: 10.1186/s13046-016-0363-6.

6.
7.

Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.

Chen TC, Hsu YL, Tsai YC, Chang YW, Kuo PL, Chen YH.

J Mol Med (Berl). 2014 Jan;92(1):53-64. doi: 10.1007/s00109-013-1083-4. Epub 2013 Sep 5.

PMID:
24005829
8.

Overexpression of SDF-1 activates the NF-κB pathway to induce epithelial to mesenchymal transition and cancer stem cell-like phenotypes of breast cancer cells.

Kong L, Guo S, Liu C, Zhao Y, Feng C, Liu Y, Wang T, Li C.

Int J Oncol. 2016 Mar;48(3):1085-94. doi: 10.3892/ijo.2016.3343. Epub 2016 Jan 15.

PMID:
26782945
9.
10.

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines.

Tsubaki M, Komai M, Fujimoto S, Itoh T, Imano M, Sakamoto K, Shimaoka H, Takeda T, Ogawa N, Mashimo K, Fujiwara D, Mukai J, Sakaguchi K, Satou T, Nishida S.

J Exp Clin Cancer Res. 2013 Sep 5;32:62. doi: 10.1186/1756-9966-32-62.

11.

MiR-487a Promotes TGF-β1-induced EMT, the Migration and Invasion of Breast Cancer Cells by Directly Targeting MAGI2.

Ma M, He M, Jiang Q, Yan Y, Guan S, Zhang J, Yu Z, Chen Q, Sun M, Yao W, Zhao H, Jin F, Wei M.

Int J Biol Sci. 2016 Feb 5;12(4):397-408. doi: 10.7150/ijbs.13475. eCollection 2016.

12.

Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.

Hugo HJ, Gunasinghe NPAD, Hollier BG, Tanaka T, Blick T, Toh A, Hill P, Gilles C, Waltham M, Thompson EW.

Breast Cancer Res. 2017 Jul 27;19(1):86. doi: 10.1186/s13058-017-0880-z.

13.

miR-381 inhibited breast cancer cells proliferation, epithelial-to-mesenchymal transition and metastasis by targeting CXCR4.

Xue Y, Xu W, Zhao W, Wang W, Zhang D, Wu P.

Biomed Pharmacother. 2017 Feb;86:426-433. doi: 10.1016/j.biopha.2016.12.051. Epub 2016 Dec 21.

PMID:
28012397
14.

Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Shen Y, Cao R, Liu W, Zhou Y, Wu Y, Tan J, Jin M, Zhong J, Zhang Q, Liu J, Zu X.

Oncol Lett. 2017 Aug;14(2):1403-1410. doi: 10.3892/ol.2017.6291. Epub 2017 Jun 1.

15.

BCSC-1 suppresses human breast cancer metastasis by inhibiting NF-κB signaling.

Di D, Chen L, Guo Y, Wang L, Zhao C, Ju J.

Int J Oncol. 2018 Mar 7. doi: 10.3892/ijo.2018.4309. [Epub ahead of print]

PMID:
29512758
16.
17.

LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.

Li J, Hao Y, Mao W, Xue X, Xu P, Liu L, Yuan J, Zhang D, Li N, Chen H, Zhao L, Sun Z, Luo J, Chen R, Zhao RC.

J Hematol Oncol. 2019 Feb 22;12(1):19. doi: 10.1186/s13045-019-0707-8.

18.

ERbeta1 represses basal breast cancer epithelial to mesenchymal transition by destabilizing EGFR.

Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JÅ.

Breast Cancer Res. 2012 Nov 16;14(6):R148. doi: 10.1186/bcr3358.

19.

Disulfiram inhibits TGF-β-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK/NF-κB/Snail pathway.

Han D, Wu G, Chang C, Zhu F, Xiao Y, Li Q, Zhang T, Zhang L.

Oncotarget. 2015 Dec 1;6(38):40907-19. doi: 10.18632/oncotarget.5723.

20.

Secretome of tumor-associated leukocytes augment epithelial-mesenchymal transition in positive lymph node breast cancer patients via activation of EGFR/Tyr845 and NF-κB/p65 signaling pathway.

Elghonaimy EA, Ibrahim SA, Youns A, Hussein Z, Nouh MA, El-Mamlouk T, El-Shinawi M, Mostafa Mohamed M.

Tumour Biol. 2016 Sep;37(9):12441-12453. Epub 2016 Jun 22. Erratum in: Tumour Biol. 2016 Oct;37(10 ):14333.

PMID:
27329104

Supplemental Content

Support Center